We work side-by-side with the patient community across all areas of our business. This includes addressing global inequities in access to healthcare and increasing scientific exchanges.
Vanessa Mahamat after her training in a pharmacy in Chad
In 2025, we focused on scientific exchanges with patient advocacy groups (PAGs), increased partnerships on shared policy interests, and improved interactions between patients and our researchers. In addition, we enhanced Patient Safety and Pharmacovigilance (PSPV) engagement with patient organizations, raising awareness of the value of PSPV data and how to support its development.
24 dedicated Patient Safety and Pharmacovigilance initiatives (+380% vs 2024)
As part of our work, we address access gaps by continuing to secure equitable access to medicines, building on significant efforts to deliver treatments and vaccines through local humanitarian organizations.
We reached a significant milestone:
1 million individuals living with non-communicable diseases reached in 2025
We work across 40 low- and middle-income countries
Learn more about our work
![]()
“Sanofi is honestly one of our favorite partners. They are easy to work with, value patients and advocacy, and bring senior leadership into discussion with advocacy partners in a way that I think is above most of their peer orgs.”